Vaxart Inc (AVIR):企業の財務・戦略的SWOT分析

◆英語タイトル:Vaxart Inc (AVIR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12809
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Vaxart Inc (AVIR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vaxart Inc (Vaxart) formerly Aviragen Therapeutics Inc is a clinical-stage pharmaceutical company that develops oral recombinant vaccines based on its proprietary delivery platform. It is developing prophylactic vaccine candidates for a range of infectious diseases including norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company is also developing a therapeutic immune-oncology vaccine which targets cervical cancer and dysplasia caused by human papillomavirus (HPV). Vaxart’s vaccines are room temperature-stable tablets that can be stored and shipped without refrigeration. Vaxart is headquartered in San Francisco, California, the US.

Vaxart Inc Key Recent Developments

Nov 28,2018: Vaxart to Present at World Vaccine and Immunotherapy Congress West Coast 2018
Nov 09,2018: Vaxart announces third quarter 2018 financial results and provides corporate update
Oct 04,2018: New Data from Phase 2 Flu Challenge Study Demonstrates Vaxart s Oral H1 Flu Vaccine Generated Protective Mucosal Immunity
Oct 04,2018: New Data from Phase 2 Flu Challenge Study Demonstrates Vaxart s Oral H1 Flu Vaccine Generated Protective Mucosal Immunity
Oct 04,2018: New Data from Phase 2 Flu Challenge Study Demonstrates Vaxart s Oral H1 Flu Vaccine Generated Protective Mucosal Immunity

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Vaxart Inc – Key Facts 6
Vaxart Inc – Key Employees 7
Vaxart Inc – Key Employee Biographies 8
Vaxart Inc – Major Products and Services 9
Vaxart Inc – History 10
Vaxart Inc – Company Statement 12
Vaxart Inc – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Vaxart Inc – Business Description 15
Vaxart Inc – Corporate Strategy 16
Vaxart Inc – SWOT Analysis 17
SWOT Analysis – Overview 17
Vaxart Inc – Strengths 17
Vaxart Inc – Weaknesses 18
Vaxart Inc – Opportunities 19
Vaxart Inc – Threats 20
Vaxart Inc – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Vaxart Inc, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Nov 28, 2018: Vaxart to Present at World Vaccine and Immunotherapy Congress West Coast 2018 31
Nov 09, 2018: Vaxart announces third quarter 2018 financial results and provides corporate update 32
Oct 04, 2018: New Data from Phase 2 Flu Challenge Study Demonstrates Vaxart s Oral H1 Flu Vaccine Generated Protective Mucosal Immunity 33
Oct 04, 2018: New Data from Phase 2 Flu Challenge Study Demonstrates Vaxart s Oral H1 Flu Vaccine Generated Protective Mucosal Immunity 35
Aug 09, 2018: Vaxart announces second quarter 2018 financial results and corporate update 36
May 15, 2018: Vaxart Announces First Quarter 2018 Financial Results and Corporate Update 37
Apr 19, 2018: Vaxart Appoints Brant Biehn As Senior Vice President, Commercial Operations 38
Apr 16, 2018: Vaxart to Present at Two Upcoming Medical Meetings 39
Nov 02, 2017: Aviragen Therapeutics Reports First Quarter of Fiscal Year 2018 Financial Results 40
Aug 31, 2017: Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results 41
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Vaxart Inc, Key Facts 6
Vaxart Inc, Key Employees 7
Vaxart Inc, Key Employee Biographies 8
Vaxart Inc, Major Products and Services 9
Vaxart Inc, History 10
Vaxart Inc, Subsidiaries 13
Vaxart Inc, Key Competitors 21
Vaxart Inc, Ratios based on current share price 22
Vaxart Inc, Annual Ratios 23
Vaxart Inc, Annual Ratios (Cont...1) 24
Vaxart Inc, Interim Ratios 26
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Vaxart Inc, Recent Deals Summary 30
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45

List of Figures
Vaxart Inc, Performance Chart (2013 - 2017) 25
Vaxart Inc, Ratio Charts 27
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Vaxart Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

★海外企業調査レポート[Vaxart Inc (AVIR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bone Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary Bone Solutions Inc (BSI) is a medical device company that offers orthobiologics technology solutions. The company also develops magnesium oxide based technologies for multitude of orthopedic applications. It offers osteocrete bone graft substitute that provides adhere ligaments and tendons t …
  • Nova Kreditna banka Maribor d. d.:企業の戦略・SWOT・財務分析
    SummaryNova Kreditna banka Maribor d. d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …
  • Wayne State University:企業のM&A・提携動向(医療分野)
    Summary Wayne State University (WSU) is a public research university that offers academic and certificate programs for graduates and undergraduates. The university offers academic programs including business, engineering, information science, arts and sciences, law, medicine, nursing, health science …
  • Oil India Limited:企業の戦略・SWOT・財務分析
    SummaryOil India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • MAN SE (MAN)-エネルギー分野:企業M&A・提携分析
    Summary MAN SE (MAN) is a commercial vehicle and mechanical engineering company. It involves in designing, developing, manufacture and sale of wide range of engineering goods such as trucks, buses, diesel engines, turbo machinery, and special gear systems. The company operates production facilities …
  • KYOCERA Medical Corporation:企業の戦略的SWOT分析
    KYOCERA Medical Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • V. F. Corporation:企業の戦略・SWOT・財務分析
    SummaryV. F. Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Meridian Bioscience, Inc. (VIVO):企業の製品パイプライン分析2016
    Summary Meridian Bioscience, Inc. (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, …
  • AmSurg Corp. (AMSG):企業概要、財務及び戦略的SWOT分析
    Summary Amsurg Corp. (AmSurg) is a healthcare service provider. The company develops acquires and operates outpatient surgery centers. It provides services in area of gastroenterology, ophthalmology, knee and shoulder arthroscopy, and orthopedic. Amsurg’s surgery centers offer patient registration, …
  • MiaSole Hi-Tech Corp.:企業のM&A・提携動向(発電分野)
    Summary MiaSole Hi-Tech Corp. (MiaSole) is an alternative energy company that designs, develops, manufactures and markets thin-film photovoltaic solar cells and panels. The company offers products which include flex-02N and flex-02NL; and flex-02W. It offers photovoltaic products for large-scale roo …
  • Mission Pharmacal Company:企業の戦略的SWOT分析
    Mission Pharmacal Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • InfraReDx Inc-医療機器分野:企業M&A・提携分析
    Summary Infraredx Inc (Infraredx), a subsidiary of Nipro Corp is a medical device company that provides cardiovascular imaging solutions. The company offers TVC imaging system, a dual-modality intravascular imaging system that assesses plaque composition and vessel structure. Its TVC imaging system …
  • ProterixBio Inc:企業のM&A・提携動向(医療機器分野)
    Summary ProterixBio Inc (ProterixBio), formerly known as BioScale, Inc. is a medical device company that manufactures and markets the ViBE platform products. The company offers ViBE platform, acoustic assays; ViBE software and custom assays. Its ViBE platform enables non-optical detection and sensit …
  • Dynemic Products Ltd.:企業の戦略・SWOT・財務情報
    Dynemic Products Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dynemic Products Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Enbridge Energy Partners, L.P. (EEP):企業のM&A・提携動向(エネルギー分野)
    Summary Enbridge Energy Partners, L.P. (EEP) is an independent midstream energy company. The company owns and operates crude oil and liquid petroleum transportation and storage assets, and natural gas gathering, treating, processing, transportation and marketing assets in the US. Its portfolio of as …
  • Tornier N.V. (TRNX):企業概要、財務及び戦略的SWOT分析
    Summary Tornier N.V. (Tornier) is a global medical device company. The company’s products include upper limb, lower limb, sports medicine, biologics and cement. Its upper limb products include shoulder, elbow and hand and wrist. Tornier offers lower limb products such as hip, knee and ankle – foot. …
  • OSI Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OSI Pharmaceuticals, Inc. Merge …
  • AdvantEdge Healthcare Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary AdvantEdge Healthcare Solutions Inc (AdvantEdge) is a healthcare service provider that offers medical billing, coding and revenue cycle management solutions. The center’s solutions include medical billing, coding, reporting, dashboards and business intelligence, consulting and practice manag …
  • Cummins Inc (CMI):電力:M&Aディール及び事業提携情報
    Summary Cummins Inc. (Cummins), formerly Cummins Engine Company, is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment dev …
  • Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆